PA8657801A1 - Aminalcoholes triciclicos, procedimientos para su preparacion - Google Patents
Aminalcoholes triciclicos, procedimientos para su preparacionInfo
- Publication number
- PA8657801A1 PA8657801A1 PA20058657801A PA8657801A PA8657801A1 PA 8657801 A1 PA8657801 A1 PA 8657801A1 PA 20058657801 A PA20058657801 A PA 20058657801A PA 8657801 A PA8657801 A PA 8657801A PA 8657801 A1 PA8657801 A1 PA 8657801A1
- Authority
- PA
- Panama
- Prior art keywords
- tricycle
- procedures
- preparation
- aminalcoholes
- aminoalcoholes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004063227A DE102004063227A1 (de) | 2004-12-22 | 2004-12-22 | Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8657801A1 true PA8657801A1 (es) | 2006-12-07 |
Family
ID=36250953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20058657801A PA8657801A1 (es) | 2004-12-22 | 2005-12-22 | Aminalcoholes triciclicos, procedimientos para su preparacion |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JP2008524300A (fr) |
| KR (1) | KR20070089948A (fr) |
| CN (1) | CN101087780A (fr) |
| AR (1) | AR055016A1 (fr) |
| AU (1) | AU2005318354A1 (fr) |
| BR (1) | BRPI0519710A2 (fr) |
| CA (1) | CA2586973A1 (fr) |
| DE (1) | DE102004063227A1 (fr) |
| GT (1) | GT200500385A (fr) |
| IL (1) | IL183060A0 (fr) |
| MX (1) | MX2007007420A (fr) |
| PA (1) | PA8657801A1 (fr) |
| PE (1) | PE20061197A1 (fr) |
| WO (1) | WO2006066950A2 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005034939A1 (fr) | 2003-10-08 | 2005-04-21 | Schering Aktiengesellschaft | Derives de tetrahydronaphtalene a substitution 1-amino-2-oxy, procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires |
| US7662821B2 (en) | 2003-10-08 | 2010-02-16 | Bayer Schering Pharma Ag | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| US7638515B2 (en) | 2003-10-08 | 2009-12-29 | Bayer Schering Pharma Aktiengesellschaft | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| US20080153859A1 (en) | 2004-04-05 | 2008-06-26 | Hartmut Rehwinkel | Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| US7297700B2 (en) | 2005-03-24 | 2007-11-20 | Renovis, Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| EP1834948A1 (fr) | 2006-03-15 | 2007-09-19 | Bayer Schering Pharma Aktiengesellschaft | Derives de tetrahydronaphtalene , procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires |
| TWI464148B (zh) | 2006-03-16 | 2014-12-11 | Evotec Us Inc | 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途 |
| EP1917963A1 (fr) * | 2006-10-31 | 2008-05-07 | Bayer Schering Pharma Aktiengesellschaft | Imidazoles cycliques substitués par un groupe phényle, procédé pour leur préparation et leur utilisation comme des agents anti-inflammatoires |
| EP2072509A1 (fr) | 2007-12-18 | 2009-06-24 | Bayer Schering Pharma Aktiengesellschaft | 1-aryl-1H-quinoline-2-ones : leur procédé de fabrication et leur utilisation en tant qu'agents anti-inflammatoires |
| AU2013216935C1 (en) | 2012-02-08 | 2017-12-14 | John Emmerson Campbell | Heteroaryl compounds and methods of use thereof |
| WO2018023072A2 (fr) | 2016-07-29 | 2018-02-01 | Sunovion Pharmaceuticals, Inc. | Composés et compositions, et utilisations associées |
| EP3490607A4 (fr) | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | Composés et compositions, et utilisations associées |
| JP7191085B2 (ja) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | イソクロマン化合物およびその使用 |
| MX2021010880A (es) | 2019-03-14 | 2022-01-18 | Sunovion Pharmaceuticals Inc | Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas. |
| KR102462991B1 (ko) * | 2020-11-02 | 2022-11-04 | 한국해양과학기술원 | 남극-유래 진균 균주 아크레모늄(Acremonium sp.) SF-7394에서 분리한 화합물 및 이를 포함하는 항염증, 항암 또는 항당뇨용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10038639A1 (de) * | 2000-07-28 | 2002-02-21 | Schering Ag | Nichtsteroidale Entzündungshemmer |
| NZ535889A (en) * | 2002-03-26 | 2006-03-31 | Boehringer Ingelheim Pharma | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| DE10215316C1 (de) * | 2002-04-02 | 2003-12-18 | Schering Ag | Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer |
| WO2005034939A1 (fr) * | 2003-10-08 | 2005-04-21 | Schering Aktiengesellschaft | Derives de tetrahydronaphtalene a substitution 1-amino-2-oxy, procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires |
| GB0418045D0 (en) * | 2004-08-12 | 2004-09-15 | Glaxo Group Ltd | Compounds |
| DE102004044680B3 (de) * | 2004-09-09 | 2006-06-08 | Schering Ag | Alkyliden-Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate |
-
2004
- 2004-12-22 DE DE102004063227A patent/DE102004063227A1/de not_active Withdrawn
-
2005
- 2005-12-20 CA CA002586973A patent/CA2586973A1/fr not_active Abandoned
- 2005-12-20 KR KR1020077014116A patent/KR20070089948A/ko not_active Application Discontinuation
- 2005-12-20 BR BRPI0519710-4A patent/BRPI0519710A2/pt not_active Application Discontinuation
- 2005-12-20 CN CNA2005800442843A patent/CN101087780A/zh active Pending
- 2005-12-20 MX MX2007007420A patent/MX2007007420A/es not_active Application Discontinuation
- 2005-12-20 JP JP2007547379A patent/JP2008524300A/ja active Pending
- 2005-12-20 WO PCT/EP2005/013943 patent/WO2006066950A2/fr not_active Application Discontinuation
- 2005-12-20 AU AU2005318354A patent/AU2005318354A1/en not_active Abandoned
- 2005-12-22 GT GT200500385A patent/GT200500385A/es unknown
- 2005-12-22 PA PA20058657801A patent/PA8657801A1/es unknown
- 2005-12-22 AR ARP050105486A patent/AR055016A1/es not_active Application Discontinuation
-
2006
- 2006-01-03 PE PE2006000009A patent/PE20061197A1/es not_active Application Discontinuation
-
2007
- 2007-05-08 IL IL183060A patent/IL183060A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007007420A (es) | 2007-07-17 |
| PE20061197A1 (es) | 2006-12-07 |
| BRPI0519710A2 (pt) | 2009-03-10 |
| IL183060A0 (en) | 2007-09-20 |
| AU2005318354A1 (en) | 2006-06-29 |
| DE102004063227A1 (de) | 2006-07-06 |
| CA2586973A1 (fr) | 2006-06-29 |
| JP2008524300A (ja) | 2008-07-10 |
| CN101087780A (zh) | 2007-12-12 |
| WO2006066950A2 (fr) | 2006-06-29 |
| GT200500385A (es) | 2006-08-03 |
| KR20070089948A (ko) | 2007-09-04 |
| WO2006066950A3 (fr) | 2006-08-17 |
| AR055016A1 (es) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8657801A1 (es) | Aminalcoholes triciclicos, procedimientos para su preparacion | |
| CR11373A (es) | COMPUESTOS DE TIENOPIRIMIDINA Y PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE mTOR CINASA Y PI3 CINASA | |
| CR10328A (es) | Compuestos organicos | |
| HN2008001191A (es) | Compuestos de biciclolactama sustituida | |
| GT201000023A (es) | Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met. | |
| ECSP077271A (es) | Derivados de pirimidina | |
| CR11241A (es) | Compuestos de pirazol y su uso como inhibidores de raf | |
| HN2003000285A (es) | Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesterasa | |
| UY30748A1 (es) | Compuesto0s novedosos | |
| NI201000005A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico. | |
| ECSP077259A (es) | Derivados de pirimidina | |
| CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
| ECSP088925A (es) | Nitrilos espirocíclicos como inhibidores de proteasa | |
| ECSP088740A (es) | Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios | |
| UY29434A1 (es) | Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como inhibidores de la inflamacinn | |
| PA8644701A1 (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios | |
| UY30801A1 (es) | Compuestos calciliticos | |
| CR9058A (es) | Derivados de indol como inhibidores de la adenilato ciclasa soluble | |
| PA8668901A1 (es) | Derivados de tetrahidronaftalina, procedimientos para su preparacion y su uso como antiinflamatorios | |
| UY31139A1 (es) | Formas cristalinas de 3-(2r-tetrahidrofuril-metil)-2-tioxantina | |
| UY30235A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
| PA8666801A1 (es) | Derivado de 5h-bensociclohepteno, procedimiento para su preparacion y su uso como antiinflamatorios | |
| CR9578A (es) | Inhibidores de la adenilato ciclasa soluble | |
| UY30236A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
| UY30237A1 (es) | Inhibidores de la adenilato ciclasa soluble |